Katherine Andersen Overview
- Company
- HSBC Holdings
- Primary Position
-
Head of Life Sci...
- Primary Industry
-
Healthcare
- Med. Deal Size
-
Katherine Andersen General Information
Biography
Ms. Katherine Andersen served as Head of Life Science and Healthcare, at HSBC USA Commercial Banking at HSBC Holdings. She served as Head of US Life Science & Healthcare at Silicon Valley Bank. She also sits on the Board of Directors for SVB's Joint Venture in China, SPD Silicon Valley Bank. Before SVB, she was a senior vice president for Wells Fargo Bank leading the life sciences business development and relationship management efforts in the Northeast. Before that, she was a director at Wells Fargo Capital Finance focused on front-end business development and underwriting structured loans across various industries. Before Wells, she held various positions across mergers and acquisitions, finance, equity derivatives, audit, and management while at Affiliated Managers Group, Merrill Lynch, GE Corporate Audit Staff, and GE Capital. She has also completed Dartmouth's Tuck Executive Leadership and Strategic Impact Program, Wells Fargo's Transformational Leadership Program, the Program on Negotiation at Harvard Law School, and the GE Capital Financial Management Program. Away from work
Contact Information
Address
- 8 Canada Square
- London E14 5HQ
- England, United Kingdom
Katherine Andersen Positions (1)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
HSBC Holdings | Company | Head of Life Science and Healthcare, HSBC USA Commercial Banking | London, United Kingdom | International Banks |
Katherine Andersen Lead Partner on Deals (3)
Katherine Andersen has been the lead partner on 3 deals. Their latest deal was with Shanghai Innovation Bank, a national banks company. The deal was made for on 30-Sep-2021.
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
Shanghai Innovation Bank | 30-Sep-2021 | Corporate | Completed | National Banks | Shanghai, China | |
Vericel | 01-Sep-2016 | Completed | Biotechnology | Cambridge, MA | ||
Ocata Therapeutics | 19-Aug-2015 | Completed | Biotechnology | Marlborough, MA |
Katherine Andersen Network (38)
Board Members (1)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Shanghai Innovation Bank | Shanghai Innovation Bank | Shanghai, China |
Portfolio Executives (37)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Sophie Xia | Shanghai Innovation Bank | Managing Director & Head of Marketing and PR | 30-Sep-2021 | Shanghai, China |
Cheng Ying | Shanghai Innovation Bank | Deputy President & Chief Risk Control Officer | 30-Sep-2021 | Shanghai, China |
Shanghai Innovation Bank | Deputy President & Chief Compliance Officer | 30-Sep-2021 | Shanghai, China | |
Shanghai Innovation Bank | Deputy President & Chief Financial Officer | 30-Sep-2021 | Shanghai, China | |
Shanghai Innovation Bank | Managing Director & Head of Corporate Banking | 30-Sep-2021 | Shanghai, China |
Katherine Andersen FAQs
-
Who is Katherine Andersen?
Ms. Katherine Andersen served as Head of Life Science and Healthcare, at HSBC USA Commercial Banking at HSBC Holdings.
-
How much does Katherine Andersen typically invest?
Katherine Andersen's median deal size is
. -
What is Katherine Andersen’s main position?
Katherine Andersen’s primary position is Head of Life Science and Healthcare, HSBC USA Commercial Banking.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »